Boehringer Ingelheim Vetmedica GmbH

Firma Premium

Boehringer Ingelheim Animal Health Business Unit

Boehringer Ingelheim is the second largest animal health business in the world, with net sales of 4 billion euros in 2019 and presence in more than 150 markets.

As the lives of animals and humans are intertwined, across the globe, our 10,000 employees are dedicated to enhancing the well-being of both – through science and innovation, as well as with their commitment and passion.

Respect for animals, people and the environment is at the heart of what we do. We develop medicines, services and innovative digital technologies to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society- threatening diseases.

For more information visit: www.boehringer-ingelheim.com/animal-health/overview

 

TwitterLinkedinTelegramTelegram

American PRRSpective 2026 - Overcoming Apathy in the Workforce - By Larry Firkins

Workforce motivation is a key factor for pig production. Do you know how to overcome the apathy in the workforce of your operations?
1 Gefällt mirkommentieren
teilen
Meine Favoriten
TwitterLinkedinTelegramTelegram

Asian PRRSpective 2026 - Controlling Hyperpathogenic PRRS. by Daniel Linhares & Marius Kunze

Asian PRRSpective is one of the leading international meetings focused on PRRS, bringing together veterinarians, researchers, swine producers, and industry professionals.
1 Gefällt mirkommentieren
teilen
Meine Favoriten
TwitterLinkedinTelegramTelegram

Variation Impacts Performance​

Response variation across a group can impact targets, consistency and profitability.​ Explore how variability affects performance across swine production systems.​
Gefällt mirkommentieren
teilen
Meine Favoriten
TwitterLinkedinTelegramTelegram

The concept of Single and Double 12

Gilts should be in a biosecure facility (i.e., quarantine), avoiding unexpected infections before introduction to sow farms, to avoid the disease outbreaks in sows and offspring.
1 Gefällt mirkommentieren
teilen
Meine Favoriten
TwitterLinkedinTelegramTelegram

Are You Confident in Your PRRS Vaccine’s Cross-Protection?

Porcine reproductive and respiratory syndrome (PRRS) continues to be the most economically significant disease affecting U.S. swine herds today, estimated to be about $1.2 billion
1 Gefällt mirkommentieren
teilen
Meine Favoriten
TwitterLinkedinTelegramTelegram

Protecting nursery performance

In today’s production environment, understanding and addressing the collective impact of nursery systemic pathogens is essential to setting pigs up for long-term success
1 Gefällt mirkommentieren
teilen
Meine Favoriten

Kontakt:

Kontaktieren Sie uns über das folgende Formular.

Boehringer Ingelheim Vetmedica GmbH ist in den folgenden Kategorien vertreten